Literature DB >> 12136404

The cost of diabetes Type II in Europe: the CODE-2 Study.

M Massi-Benedetti1.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12136404     DOI： 10.1007/s00125-002-0860-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  19 in total

1.  The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group.

Authors: 
Journal:  Diabetes Care       Date:  2000-11       Impact factor: 19.112

Review 2.  Type 2 diabetes mellitus: the grand overview.

Authors:  R E Ratner
Journal:  Diabet Med       Date:  1998       Impact factor: 4.359

3.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

Authors:  S M Haffner; M P Stern; H P Hazuda; B D Mitchell; J K Patterson
Journal:  JAMA       Date:  1990-06-06       Impact factor: 56.272

Review 4.  Diabetes epidemiology as a tool to trigger diabetes research and care.

Authors:  P Z Zimmet
Journal:  Diabetologia       Date:  1999-05       Impact factor: 10.122

5.  Economic consequences of diabetes mellitus in the U.S. in 1997. American Diabetes Association.

Authors: 
Journal:  Diabetes Care       Date:  1998-02       Impact factor: 19.112

6.  Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections.

Authors:  H King; R E Aubert; W H Herman
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

7.  Cardiovascular risk factors prior to the development of non-insulin-dependent diabetes mellitus in persons with impaired glucose tolerance: the Hoorn Study.

Authors:  G Nijpels; C Popp-Snijders; P J Kostense; L M Bouter; R J Heine
Journal:  J Clin Epidemiol       Date:  1997-09       Impact factor: 6.437

8.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245
View more
  31 in total

1.  Development and Testing of the Insulin Treatment Experience Questionnaire (ITEQ).

Authors:  Jörn Moock; Franz Hessel; Diana Ziegeler; Thomas Kubiak; Thomas Kohlmann
Journal:  Patient       Date:  2010-03-01       Impact factor: 3.883

2.  Direct medical costs for patients with type 2 diabetes and related complications: a prospective cohort study based on the Korean National Diabetes Program.

Authors:  Tae Ho Kim; Ki Hong Chun; Hae Jin Kim; Seung Jin Han; Dae Jung Kim; Jiyeong Kwak; Young Seol Kim; Jeong Taek Woo; Yongsoo Park; Moonsuk Nam; Sei Hyun Baik; Kyu Jeung Ahn; Kwan Woo Lee
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

Review 3.  A Systematic Review of the Economic and Humanistic Burden of Gout.

Authors:  Gemma E Shields; Stephen M Beard
Journal:  Pharmacoeconomics       Date:  2015-10       Impact factor: 4.981

4.  Comparing the sensitivity of EQ-5D, SF-6D and 15D utilities to the specific effect of diabetic complications.

Authors:  Nick Kontodimopoulos; Evelina Pappa; Zinovia Chadjiapostolou; Eleni Arvanitaki; Angelos A Papadopoulos; Dimitris Niakas
Journal:  Eur J Health Econ       Date:  2010-12-05

5.  Quality of diabetes care in Austrian diabetic patients willing to participate in a DMP - at baseline.

Authors:  Maria Flamm; Henrike Winkler; Sigrid Panisch; Peter Kowatsch; Gert Klima; Bernhard Fürthauer; Raimund Weitgasser; Andreas C Sönnichsen
Journal:  Wien Klin Wochenschr       Date:  2011-06-22       Impact factor: 1.704

6.  Progression rates from HbA1c 6.0-6.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis.

Authors:  D H Morris; K Khunti; F Achana; B Srinivasan; L J Gray; M J Davies; D Webb
Journal:  Diabetologia       Date:  2013-04-13       Impact factor: 10.122

7.  Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial.

Authors:  M J Davies; S Heller; T C Skinner; M J Campbell; M E Carey; S Cradock; H M Dallosso; H Daly; Y Doherty; S Eaton; C Fox; L Oliver; K Rantell; G Rayman; K Khunti
Journal:  BMJ       Date:  2008-02-14

8.  [Health status of type 2 diabetics in Austria - perspective of a quality improvement initiative].

Authors:  Ivo Rakovac; Johannes Plank; Klaus Jeitler; Peter Beck; Sabine Seereiner; Peter Mrak; Bernd Bauer; Thomas R Pieber
Journal:  Wien Med Wochenschr       Date:  2009

9.  The economic costs of diabetes: a population-based study in Tehran, Iran.

Authors:  A Esteghamati; O Khalilzadeh; M Anvari; A Meysamie; M Abbasi; M Forouzanfar; F Alaeddini
Journal:  Diabetologia       Date:  2009-05-28       Impact factor: 10.122

10.  N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.

Authors:  Khaled A Ahmed; Sekaran Muniandy; Ikram S Ismail
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.